Impaired Cerebral Vasomotor Reactivity in Alzheimer’s Disease

Background. Recent studies have shown that cerebral vascularity may be impaired in Alzheimer’s disease. Cerebral vasomotor reactivity could be an important biomarker for this pathology. Aims. The aim of this study was to investigate the alterations in cerebral vascular motorre activity in Alzheimer’...

Descripción completa

Detalles Bibliográficos
Autores principales: Góngora Rivera, Juan Fernando, Cordero Pérez, Adolfo, González Aquines, Alejandro, Anaya Escamilla, Antonio, Villarreal Garza, Eduardo, Espinosa Ortega, Meztli, Salinas Carmona, Mario César, Ortiz Jiménez, Xóchitl A.
Formato: Artículo
Lenguaje:inglés
Publicado: 2018
Materias:
Acceso en línea:http://eprints.uanl.mx/16623/1/223.pdf
_version_ 1838550997122678784
author Góngora Rivera, Juan Fernando
Cordero Pérez, Adolfo
González Aquines, Alejandro
Anaya Escamilla, Antonio
Villarreal Garza, Eduardo
Espinosa Ortega, Meztli
Salinas Carmona, Mario César
Ortiz Jiménez, Xóchitl A.
author_facet Góngora Rivera, Juan Fernando
Cordero Pérez, Adolfo
González Aquines, Alejandro
Anaya Escamilla, Antonio
Villarreal Garza, Eduardo
Espinosa Ortega, Meztli
Salinas Carmona, Mario César
Ortiz Jiménez, Xóchitl A.
author_sort Góngora Rivera, Juan Fernando
collection Repositorio Institucional
description Background. Recent studies have shown that cerebral vascularity may be impaired in Alzheimer’s disease. Cerebral vasomotor reactivity could be an important biomarker for this pathology. Aims. The aim of this study was to investigate the alterations in cerebral vascular motorre activity in Alzheimer’s disease subject sand to associate the sechanges with the ir cognitivescores. Methods. We recruited subjects with a diagnosis of Alzheimer’s disease and healthy controls. Demographic, clinical, imaging, and cognitive test were obtained. Then all participants performed a cerebral vascular motorre activity test with 7% CO2 and cerebral blood flow velocities (CBFV) were recorded with transcranial doppler ultrasound before and after the test. Results. Wer ecruited 45 subjects, 26 (21 female) Alzheimer’s disease participants and 19 (15 female) healthy controls. There were no differences in baseline cerebral blood flow velocities between the groups. After the cerebral vasomotor reactivity test, absolute mean difference in mean CBFV (ΔCBFV-m)was 8.70±4.14 versus4.81±6.96 (p<0.01), respectively. Calculated percentage of change (%CVMR) was lower in the ADgroup7.45±18.25versus23.29±17.48, and there was a positive but weak correlation with mini-mental scores.
format Article
id eprints-16623
institution UANL
language English
publishDate 2018
record_format eprints
spelling eprints-166232025-07-16T15:59:01Z http://eprints.uanl.mx/16623/ Impaired Cerebral Vasomotor Reactivity in Alzheimer’s Disease Góngora Rivera, Juan Fernando Cordero Pérez, Adolfo González Aquines, Alejandro Anaya Escamilla, Antonio Villarreal Garza, Eduardo Espinosa Ortega, Meztli Salinas Carmona, Mario César Ortiz Jiménez, Xóchitl A. RC Medicina Interna, Psiquiatría, Neurología Background. Recent studies have shown that cerebral vascularity may be impaired in Alzheimer’s disease. Cerebral vasomotor reactivity could be an important biomarker for this pathology. Aims. The aim of this study was to investigate the alterations in cerebral vascular motorre activity in Alzheimer’s disease subject sand to associate the sechanges with the ir cognitivescores. Methods. We recruited subjects with a diagnosis of Alzheimer’s disease and healthy controls. Demographic, clinical, imaging, and cognitive test were obtained. Then all participants performed a cerebral vascular motorre activity test with 7% CO2 and cerebral blood flow velocities (CBFV) were recorded with transcranial doppler ultrasound before and after the test. Results. Wer ecruited 45 subjects, 26 (21 female) Alzheimer’s disease participants and 19 (15 female) healthy controls. There were no differences in baseline cerebral blood flow velocities between the groups. After the cerebral vasomotor reactivity test, absolute mean difference in mean CBFV (ΔCBFV-m)was 8.70±4.14 versus4.81±6.96 (p<0.01), respectively. Calculated percentage of change (%CVMR) was lower in the ADgroup7.45±18.25versus23.29±17.48, and there was a positive but weak correlation with mini-mental scores. 2018-09-09 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/16623/1/223.pdf http://eprints.uanl.mx/16623/1.haspreviewThumbnailVersion/223.pdf Góngora Rivera, Juan Fernando y Cordero Pérez, Adolfo y González Aquines, Alejandro y Anaya Escamilla, Antonio y Villarreal Garza, Eduardo y Espinosa Ortega, Meztli y Salinas Carmona, Mario César y Ortiz Jiménez, Xóchitl A. (2018) Impaired Cerebral Vasomotor Reactivity in Alzheimer’s Disease. International Journal of Alzheimer's Disease, 2018. pp. 1-5. ISSN 2090-8024 http://doi.org/10.1155/2018/9328293 doi:10.1155/2018/9328293
spellingShingle RC Medicina Interna, Psiquiatría, Neurología
Góngora Rivera, Juan Fernando
Cordero Pérez, Adolfo
González Aquines, Alejandro
Anaya Escamilla, Antonio
Villarreal Garza, Eduardo
Espinosa Ortega, Meztli
Salinas Carmona, Mario César
Ortiz Jiménez, Xóchitl A.
Impaired Cerebral Vasomotor Reactivity in Alzheimer’s Disease
thumbnail https://rediab.uanl.mx/themes/sandal5/images/online.png
title Impaired Cerebral Vasomotor Reactivity in Alzheimer’s Disease
title_full Impaired Cerebral Vasomotor Reactivity in Alzheimer’s Disease
title_fullStr Impaired Cerebral Vasomotor Reactivity in Alzheimer’s Disease
title_full_unstemmed Impaired Cerebral Vasomotor Reactivity in Alzheimer’s Disease
title_short Impaired Cerebral Vasomotor Reactivity in Alzheimer’s Disease
title_sort impaired cerebral vasomotor reactivity in alzheimer s disease
topic RC Medicina Interna, Psiquiatría, Neurología
url http://eprints.uanl.mx/16623/1/223.pdf
work_keys_str_mv AT gongorariverajuanfernando impairedcerebralvasomotorreactivityinalzheimersdisease
AT corderoperezadolfo impairedcerebralvasomotorreactivityinalzheimersdisease
AT gonzalezaquinesalejandro impairedcerebralvasomotorreactivityinalzheimersdisease
AT anayaescamillaantonio impairedcerebralvasomotorreactivityinalzheimersdisease
AT villarrealgarzaeduardo impairedcerebralvasomotorreactivityinalzheimersdisease
AT espinosaortegameztli impairedcerebralvasomotorreactivityinalzheimersdisease
AT salinascarmonamariocesar impairedcerebralvasomotorreactivityinalzheimersdisease
AT ortizjimenezxochitla impairedcerebralvasomotorreactivityinalzheimersdisease